← Feed

$INBX

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$INBXSEC Form 4bullish
FORSYTH DOUGLAS · Inhibrx Biosciences, Inc. · 2h agono track record yet
Long 2,500 shares of INBX
Bought 2,500 @ $114.65 avg · $286,617 · 2026-09-08

Form 4: FORSYTH DOUGLAS bought INBX

FORSYTH DOUGLAS (Director at Inhibrx Biosciences, Inc.) reported an open-market purchase of 2,500 shares of INBX at an average $114.65, roughly $286,617, in a Form 4 filed 2026-09-08.

View filing on SEC.gov →
$INBXSEC Form 4bullish
Lappe Mark · Chief Executive Officer at Inhibrx Biosciences, Inc. · 3h agono track record yet
Long 25,000 shares of INBX
Bought 25,000 @ $105.82 avg · $2,645,399 · 2026-09-08

Form 4: Lappe Mark bought INBX

Lappe Mark (Chief Executive Officer at Inhibrx Biosciences, Inc.) reported an open-market purchase of 25,000 shares of INBX at an average $105.82, roughly $2,645,399, in a Form 4 filed 2026-09-08.

View filing on SEC.gov →

End of results.